Developmental and neurochemical features of cholinergic neurons in the murine cerebral cortex
© Consonni et al; licensee BioMed Central Ltd. 2009
Received: 10 September 2008
Accepted: 09 March 2009
Published: 09 March 2009
The existence and role of intrinsic cholinergic cells in the cerebral cortex is controversial, because of their variable localization and morphology in different mammalian species. We have applied choline acetyltransferase (ChAT) immunocytochemistry to study the distribution of cholinergic neurons in the murine cerebral cortex, in the adult and during postnatal development. For more precise neurochemical identification of these neurons, the possible colocalization of ChAT with different markers of cortical neuronal populations has been analyzed by confocal microscopy. This method was also used to verify the relationship between cholinergic cells and cortical microvessels.
ChAT positive cells appeared at the end of the first postnatal week. Their density dramatically increased at the beginning of the second postnatal week, during which it remained higher than in perinatal and adult stages. In the adult neocortex, cholinergic neurons were particularly expressed in the somatosensory area, although their density was also significant in visual and auditory areas. ChAT positive cells tended to be scarce in other regions. They were mainly localized in the supragranular layers and displayed a fusiform/bipolar morphology.
The colocalization of ChAT with pyramidal neuron markers was negligible. On the other hand, more than half of the cholinergic neurons contained calretinin, but none of them expressed parvalbumin or calbindin. However, only a fraction of the ChAT positive cells during development and very few in adulthood turned out to be GABAergic, as judged from expression of GABA and its biosynthetic enzymes GAD67/65. Consistently, ChAT showed no localization with interneurons expressing green fluorescent protein under control of the GAD67 promoter in the adult neocortex. Finally, the cortical cholinergic cells often showed close association with the microvessel walls, as identified with the gliovascular marker aquaporin 4, supporting previous hypotheses on the role of cholinergic cells in modulating the cortical microcirculation.
Our results show that the development of the intracortical cholinergic system accompanies the cortical rearrangements during the second postnatal week, a crucial stage for the establishment of cortical cytoarchitecture and for synaptogenesis. Although intrinsic ChAT positive cells usually expressed calretinin, they displayed a variable GABAergic phenotype depending on marker and on cortical developmental stage.
Cholinergic transmission in the mammalian cerebral cortex is thought to play an important role in controlling the transitions towards more vigilant brain states, with implications for learning, memory and neuropathology . Most of the cholinergic innervation comes from fibres originating from basal forebrain nuclei. However, early immunocytochemical work suggested the existence of intracortical cholinergic neurons, in the rat [2–5]. Subsequently, the variability of the localization and morphology of cholinergic cells in different mammalian species has given rise to controversy about their morphological and neurochemical nature . Immunocytochemical localization of choline acetyltransferase (ChAT) labels mainly, but not exclusively, neurons in the II and III layers in the rat [3, 7], rabbit , cat , fetal Macaca mulatta , and different murine strains [11, 12]. Cholinergic cells with pyramidal shape have also been observed in the III and V layers of the human cerebral cortex [13, 14].
The function of these cells is unclear. A recent morphofunctional study addressed the physiological role and the neurochemical features of neocortical cholinergic neurons, in the mouse . In particular, electrophysiological results show that ChAT positive (ChAT+) cells are innervated by both interneurons and pyramidal cells, whereas their synaptic output on these cells is negligible. However, prolonged activation of cholinergic neurons increases the frequency of the spontaneous excitatory postsynaptic currents recorded on adjacent pyramidal neurons, by an indirect effect mediated by presynaptic nicotinic receptors. These results indicate a role of ChAT+ cells in local control of cortical microcircuits.
With regard to the neurochemical nature of ChAT+ cells, earlier morphological and neurochemical data in the rat suggested they were mainly GABAergic [16, 17], leading to the hypothesis that acetylcholine release could modulate the local inhibitory circuits. In the mouse, however, von Engelhardt et al.  showed that the expression of the mRNA for the biosynthetic enzyme for GABA (GAD67) is negligible in ChAT+ cells, although a fraction of them does express other typical interneuronal markers such as the vasoactive intestinal peptide [3, 17, 18] and calretinin [15, 19]. The vasoactive intestinal peptide-expressing cortical interneurons control microvascular dilatation in the rat . Although the main source of perivascular cholinergic innervation is the basal forebrain , experiments carried out with lesion approaches confirm that a fraction of the cholinergic cells could contribute to the local regulation of the cortical microvascular bed [22, 23]. Nevertheless, in contrast to the basal forebrain neurons that innervate large areas of cerebral cortex, cortical cholinergic neurons seem to be ideally suited for a restricted modulatory role on small cortical columnar units .
Considering that cholinergic transmission plays important roles in shaping neuronal circuits during development , new indications about the possible functions of intrinsic cholinergic cells should come from studying the timing of appearance of these cells and their distribution during development. To this purpose, we have studied the distribution of cholinergic neurons in the murine cerebral cortex, in adult and during postnatal development, by using ChAT immunocytochemistry. To produce a fuller neurochemical identification, the colocalization of ChAT with markers for interneurons and pyramidal neurons was tested by confocal microscopy. Pyramidal neurons were identified with SMI32 antibody against the non-phosphorylated epitope of the heavy subunit of mammalian neurofilaments. Interneurons were investigated by labelling GABA, GAD67, GAD65 (two isoforms of the glutamic acid decarboxylase, biosynthetic enzyme for GABA) and the calcium binding proteins (CaBPs) parvalbumin, calbindin and calretinin. As an alternative way to identify GABAergic interneurons, we have used transgenic mice expressing green fluorescent protein (GFP) under the control of the GAD67 gene promoter . Finally, the relationship of the cortical ChAT+ neurons with microvessels was investigated by means of aquaporin 4, which is the predominant water channel in the brain and is mainly expressed on the astrocytic end feet that contact the cortical microvessels .
The cortical cholinergic cell density quickly rised between postnatal day (P)4 and P8, was maintained for about two weeks and then slightly declined in the adult. These cells were mostly localized in the sensory cortical areas, especially in the upper layers. Although they usually expressed calretinin, they displayed a variable GABAergic phenotype depending on marker and on cortical developmental stage.
In the developing somatosensory cortex (Figure 2), cholinergic cells appeared between P4 and P6 (Figures 2A, 2B, 2C and 3A). Subsequently, their density considerably increased around the beginning of the second postnatal week (P8; Figures 2D, 2E and 3A), especially in the supragranular layers (Figure 2D), where they assumed the typical bipolar morphology. To estimate precisely the cholinergic cell density at the different stages, it is necessary to take into account the effect of dilution due to brain growth. Therefore, we have measured the thickness of layers in the somatosensory cortex in all the cortical fields that we have considered (Figure 3B). This procedure highlighted a genuine increase of ChAT+ neuronal population between P6 and P8. Around P10, ChAT+ cells started to populate the deep layers. At late postnatal stages (P16, P21; Figure 2E) they showed density values slightly lower than at P8, but still higher than those measured in the adult (Figure 3A).
Cholinergic cell distribution in the adult neocortex
Overall, our data highlighted a cortical cholinergic cell population with features broadly comparable to those described by previous work on rodents [3, 5, 12, 18]. The comparison with other nonhuman mammalian species shows a general similarity in the bipolar morphology of ChAT+ cells and a prevalent localization in the II and III layer, whereas the cells' distribution in neocortical regions is slightly different between species. In cats, rabbits and fetal monkeys, ChAT+ cells are fewer, compared to rodents, and appear to be distributed homogeneously also in motor and limbic areas [8–10]. In the human cortical mantle, they were mainly pyramidal and expressed in the motor cerebral cortex . Although some of these differences might depend on use of different antibodies, in general they can be probably attributed to a progressive evolutionary change of the intrinsic cortical cholinergic system, because of the functional requirements of the neocortex of different mammalian species . In the cat neocortex, for example, a strict connection of intrinsic cholinergic cells with neuronal activity after sensory stimulation has been demonstrated by experiments carried out with positron emission tomography .
Another common feature of cholinergic neurons is their frequent apposition to the walls of microarterioles and capillaries. This was confirmed by our immunofluorescence experiments on adult murine cerebral cortex, in analogy to what has been observed in the adult rat and human cortical regions [3, 14, 18].
Cholinergic cells during development
In the somatosensory cortex, the expression of ChAT immunoreactivity during postnatal development showed a slow onset during the first postnatal week. We have carried out similar tests in the rat and observed a considerable number of cholinergic neurons at P4 and P6 (Amadeo, unpublished results), in agreement with a recent analysis , which showed an appreciable ChAT+ population in rat cerebral cortex at P4.
At the beginning of the second postnatal week, the ChAT+ cells' expression showed an upsurge. Such a timing parallels the rapid invasion of cholinergic fibers known to take place in the rat during the first two postnatal weeks  and the quick rise in the expression of α3 and α7 nicotinic receptor subunits, in the forebrain . Therefore, we speculate that local acetylcholine release by cortical cholinergic cells might contribute to regulate synaptic refinement in restricted regions. This could adjust the nicotinic receptor expression , with possible regulatory effects on firing of the neighbouring cells . Through these or other mechanisms, cholinergic cells could influence the tuning to sensory inputs of the developing cortical circuitry .
A frequent association between ChAT+ cells and blood vessels was also observed during the second postnatal week, which is suggestive because maximal sprouting of new cortical vessels occurs during this stage [29–31]. This phase is characterised by cerebral remodelling, accompanied by a progressive increase in neuronal activity. This process boosts local metabolic needs that need to be suited by neoangiogenesis . The vascularity of cortical sensory areas is also characterised by marked interlaminar differences . The highest vessel density is observed in the superficial layers of the somatosensory barrel cortex , where we observe most of the cholinergic neurons. Considering that the second postnatal week is the critical period for major developmental events, such as synaptogenesis, spine formation and also gliogenesis [32, 34], we hypothesise that cortical ChAT+ cells could also regulate the vascular tone in this critical stage.
Neurochemical features of cortical cholinergic neurons
Cortical ChAT+ cells were originally hypothesised to be a subpopulation of the GABAergic cortical interneurons [16, 17], mainly because of their morphology (mostly bipolar, rarely multipolar). Our results with SMI32 antibody support the idea that these cells are not pyramidal neurons. However, a recent study suggests that in young adult mice most of the cholinergic cells are not GABAergic either, because they do not show appreciable expression of GAD67 mRNA . These cells may nonetheless derive from cell populations that are GABAergic in early stages [35, 36]. Our immunocytochemical experiments indicate that at least a fraction of ChAT+ neurons, more frequently in adulthood, display neither GABA nor GAD67/65 immunoreactivity. Consistent results were obtained by applying an independent method, i.e. studying ChAT expression in GAD67+ cells identified by GFP expression, in transgenic murine strains. In conclusion ChAT+ cells could represent an interneuronal subpopulation showing variable GABAergic features in different phases of cortical development.
These observations must be considered in the context of the data obtained with calretinin labelling. More than half of ChAT+ neurons turned out to express calretinin, something especially evident during the second postnatal week, when the presence of a considerable number of cholinergic cells facilitated our survey. Recent papers show that calretinin is expressed in most of adult cholinergic cortical neurons from rat and mouse [15, 19]. Therefore, keeping in mind the kinetics of ChAT+ cell appearance (Figure 3A), we conclude that the time-courses of calretinin and ChAT expression in cortical cholinergic cells overlap. The timing of calretinin expression is similar in the rat [37, 38], although it has not been correlated with the expression of ChAT. It is worth mentioning that the calretinin positive cortical population displays some unique developmental features, among the cortical GABAergic interneurons. First, the bipolar calretinin expressing neurons are mainly generated from the caudal part of the ganglionic eminence [36, 39, 40] or even from the subventricular zone [36, 41], whereas most cortical GABAergic neurons originate from the medial ganglionic eminence. Second, they exhibit peculiar developmental and neurochemical properties, such as postnatal increase and variability of GABA and GAD67/65 expression . It is worth noting that a late postnatal upregulation of calretinin expression in murine bipolar cortical neurons expressing GAD65 has been recently demonstrated . In our hands, antibodies against GAD65 gave poor results in localizing neuronal cell bodies. However, a weaker signal of GAD65 compared to GAD67 is not surprising, if one considers that the former has been reported to target preferentially the nerve terminals, whereas the latter is more widely distributed in cells . Nevertheless, it is possible that a fraction of the ChAT+ cortical neurons belong to a GABAergic subpopulation that migrates and expresses calretinin only in late postnatal development [42, 44].
Cholinergic neurons in the murine cerebral cortex quickly appeared at the boundary between the first and the second postnatal week, with higher density in the somatosensory areas and frequent association with microvessels. They persisted in the adult age, although with a lower density (about 50% of the peak at P8). These cells often expressed calretinin, and the time course of ChAT and calretinin appearance proceeded in parallel. The ChAT+ coexpression with GABA and GAD67 was less frequent. Basing on the pattern and timing of their appearance, we hypothesise that the cortical cholinergic cells perform a regulatory role during the cortical maturation at a sensitive stage. They could participate in the coordination of massive waves of sensory stimuli, neuronal activation, increased blood flow and progressive formation of topographical cortical sensory maps.
Preparation of cortical sections
We have studied thirty mice (FVB, Harlan, Italy), ranging from P2 to P40 (adult). Experiments were carried out in accordance with the guidelines established in the Principles of Laboratory Animal Care (directive 86/609/EEC) and all efforts were made to reduce the number of animals used. After inducing deep anaesthesia with chloral hydrate (4%, 2 mg/100 g i.p.), animals were sacrificed by intracardiac perfusion of 4% paraformaldehyde in phosphate buffer. For some animals (P7 and P40) a fixative solution with the addition of 0.5% glutaraldehyde was used to achieve better results with the polyclonal antibody anti-GABA (see below). Brains were removed and immersed in fixative medium overnight at 4°C. Coronal sections (50 μm thick) were cut with a Vibratome (VT1000S, Leica). At least 3–4 brain sections from different cortical regions, typically visual, auditory, somatosensory and motor, were selected for immunocytochemistry. Cytoarchitectonic controls were carried out according to the atlas of murine brain , on alternate sections adjacent to those processed for immunocytochemistry and stained with thionin. Sections from cerebral cortex of GFP-GAD67 transgenic mice (gift from Z. Josh Huang, Cold Spring Harbor Laboratory, NY, ), were also used for double immunofluorescence experiments.
Cortical cholinergic cells were localized by using a goat polyclonal anti-ChAT antibody (AB144P, Chemicon International Inc., 1:500), known to give reliable labelling in rodent cerebral cortex . After aldehydes quenching with NH4Cl and inactivation of endogenous peroxidases with H2O2, sections were permeabilised with 0.2% Triton X-100, in 10% normal goat serum for 30 min. Subsequently, they were incubated overnight with the primary antibody, at room temperature. This procedure was followed by incubation with biotinylated anti-goat IgG (Vector Inc., diluted 1:200), for 75 min. After washing, sections were treated with the avidin-biotinylated complex (ABC kit, Vector Inc., diluted 1:100) and then with a freshly prepared solution (0.075%) of 3-3'-diaminobenzidine tetrahydrochloride (Sigma Aldrich) and 0.002% H2O2. Finally, the sections were mounted, dehydrated and layed on coverslips. The specificity of anti-ChAT antibody was checked by processing some sections in the absence of the primary antibody, or with anti-ChAT antibody previously adsorbed with rat recombinant protein (AG220, Chemicon International Inc., 4 μg/ml). In these cases, no specific staining was ever observed. Specificity for the same antibody was also tested with immunofluorescence experiments (see below). The sections processed for single immunolabelling were examined under the light microscope (Zeiss). After a qualitative evaluation of cortical cholinergic cells at the different murine developmental stages (Figures 1 and 2) at least twelve images from different fields of somatosensory cortex from P6, P8, P16, P21 and adult mice were acquired to perform by an image analysis software (Image J) a quantitative estimation of developing cortical thicknesses and of cholinergic neurons (Figure 3). The ChAT+ cells were counted by two observers independent each other to obtain a mean value of cholinergic neurons per unit of cortical volume (1 × 107 μm3), as reported in previous papers [5, 18].
Double immunofluorescence experiments
ChAT immunocytochemistry was coupled to treatment with different neuronal and glial markers. To label cortical interneurons, we have used monoclonal antibodies against GABA (Sigma Aldrich, 1:300), GAD65 (Chemicon, 1:300) and against calretinin (SWant), calbindin (SWant) and parvalbumin (Sigma Aldrich), diluted 1:2000. For some double immunolabellings also polyclonal anti-calretinin (1:1500, SWant), anti-GABA (1:5000, Sigma Aldrich) and anti-GAD67 (1:300, Immunological Sciences) were used. To label pyramidal neurons, we have used monoclonal SMI32 antibody (Sternberger Monoclonals), diluted 1:1000 and to reveal cortical microvessels the polyclonal anti-aquaporin 4 antibody (Sigma Aldrich), diluted 1:250.
Sections from selected developmental stages (P11, P12, P16, P22, adult) and from GAD67-GFP transgenic mice were permeabilised for 30 min with 0.2% Triton X-100, diluted in PBS containing 1% bovine albumin serum, and incubated overnight in a mixture of anti-ChAT plus one of the antibodies listed above. The sections were subsequently incubated for 2 hours in a mixture of the appropriate corresponding secondary antibodies, at room temperature. ChAT antibody was always revealed with sequential treatment with biotinylated horse anti-goat IgG (Vector Inc.) and Alexa-488 or Red X labelled streptavidin (1:200, Molecular Probes). The primary monoclonal (anti-GABA, anti-GAD65, anti-CaBPs and SMI32) antibodies were detected with indocarbocyanine Cy3-conjugated donkey anti-mouse, whereas the polyclonal (anti-calretinin, anti-GABA, anti-GAD67 and anti-aquaporin 4) antibodies were identified with indocarbocyanine Cy5-conjugated donkey anti-rabbit antibody (1:200, Jackson Immunoresearch Laboratories). In Figures 4 and 5, the original emission colour of fluorochromes conjugated to secondary antibodies or streptavidin has been sometimes changed to facilitate the observation and analysis of confocal images (ChAT+ always red, other markers green or blue). Images were analyzed with a TCS SP2 AOBS laser scanning confocal microscopy (Leica Microsystems GmbH, Wetzlar). Control sections were processed in the absence of primary antibodies to test the specificity of the secondary antibodies. All of our primary antibodies produced a pattern of immunoreactivity consistent with literature [12, 26, 46, 47].
This work was supported by Italian Ministry for University and Scientific Research (grant PRIN 2005), Italian Telethon Foundation (grant GP0023Y01) and Fondazione Banca del Monte Lombardia. Confocal microscopy analysis has been carried out at the CIMAINA Center of the University of Milan. The authors thank Dr. S. Rodighiero for assistance in confocal analysis and Dr. C. Frassoni for generously providing cortical sections from GAD67-GFP transgenic mice (gift from Z. Josh Huang, Cold Spring Harbor Laboratory, NY).
- Dani JA, Bertrand D: Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol. 2007, 47: 699-729.View ArticlePubMedGoogle Scholar
- Johnston MV, Young AC, Coyle JT: Laminar distribution of cholinergic markers: effects of lesions. J Neurosci Res. 1981, 6 (5): 597-607.View ArticlePubMedGoogle Scholar
- Eckenstein F, Baughmann RW: Two types of cholinergic innervation in cortex, one co-localized with vasoactive intestinal peptide. Nature. 1984, 309: 153-155.View ArticlePubMedGoogle Scholar
- Levey AI, Wainer BH, Rye DB, Mufson EJ, Mesulam MM: Choline acetyltransferase-immunoreactive neurons intrinsic to rodent cortex and distinction from acetylcholinesterase-positive neurons. Neuroscience. 1984, 13 (2): 341-353.View ArticlePubMedGoogle Scholar
- Houser CR, Crawford GD, Salvaterra PM, Vaughn JE: Immunocytochemical localization of choline acetyltransferase in rat cerebral cortex: a study of cholinergic neurons and synapses. J Comp Neurol. 1985, 234: 17-34.View ArticlePubMedGoogle Scholar
- Semba K: Phylogenetic and ontogenic aspects of the basal forebrain cholinergic neurons and their innervation of the cerebral cortex. Prog Brain Res. Edited by: Descarries L, Krnjevic K, Steriade M. 2004, 145: 3-43.
- Mechawar N, Cozzari C, Descarries L: Cholinergic innervation in adult rat cerebral cortex: a quantitative immunocytochemical description. J Comp Neurol. 2000, 428: 305-318.View ArticlePubMedGoogle Scholar
- Varga C, Härtig W, Grosche J, Keijser J, Luiten PG, Seeger J, Brauer K, Harkany T: Rabbit forebrain cholinergic system: morphological characterization of nuclei and distribution of cholinergic terminals in the cerebral cortex and hippocampus. J Comp Neurol. 2003, 460: 597-611.View ArticlePubMedGoogle Scholar
- Avendaňo C, Umbriaco D, Dykes RW, Descarries L: Acetylcholine innervation of sensory and motor neocortical areas in adult cat: a choline acetyltransferase immunohistochemical study. J Chem Neuroanat. 1996, 11: 113-130.View ArticlePubMedGoogle Scholar
- Hendry SH, Jones RG, Killackey HP, Chalupa LM: Choline acetyltransferase-immunoreactive neurons in fetal monkey cerebral cortex. Brain Res. 1987, 465 (1-2): 313-317.View ArticlePubMedGoogle Scholar
- Mufson EJ, Cunningham MG: Observations on choline acetyltransferase containing structures in the CD-1 mouse brain. Neurosci Lett. 1988, 84 (1): 7-12.View ArticlePubMedGoogle Scholar
- Bhagwandin A, Fuxe K, Manger PR: Choline acetyltransferase immunoreactive cortical interneurons do not occur in all rodents: a study of the phylogenetic occurrence of this neural characteristic. J Chem Neuroanat. 2006, 32: 208-216.View ArticlePubMedGoogle Scholar
- Kasashima S, Kawashima A, Muroishi Y, Futakushi H, Nakanishi I, Oda Y: Neurons with choline acetyltransferase immunoreactivity and mRNA are present in the human cerebral cortex. Histochem Cell Biol. 1999, 111: 197-207.View ArticlePubMedGoogle Scholar
- Benagiano V, Virgintino D, Flace P, Girolamo F, Errede M, Roncali L, Ambrosi G: Choline acetyltransferase-containing neurons in the human parietal neocortex. Eur J Histochem. 2003, 47 (3): 253-256.View ArticlePubMedGoogle Scholar
- von Engelhardt J, Eliava M, Meyer AH, Rozov A, Monyer H: Functional characterization of intrinsic cholinergic interneurons in the cortex. J Neurosci. 2007, 27 (21): 5633-5642.View ArticlePubMedGoogle Scholar
- Kosaka T, Tauchi M, Dahl JL: Cholinergic neurons containing GABA-like and/or glutamic acid decarboxylase-like immunoreactivities in various brain regions of the rat. Exp Brain Res. 1988, 70 (3): 605-617.View ArticlePubMedGoogle Scholar
- Bayraktar T, Staiger JF, Acsady L, Cozzari C, Freud TF, Zilles K: Co-localization of vasoactive intestinal polypeptide, γ-aminobutyric acid and choline acetyltransferase in neocortical interneurons of the adult rat. Brain Res. 1997, 757: 209-217.View ArticlePubMedGoogle Scholar
- Chedotal A, Cozzari C, Faure MP, Hartman BK, Hamel E: Distinct choline acetyltrasnferase (ChAT) and vasoactive intestinal polypeptide (VIP) bipolar neurons project to local blood vessels in the rat cerebral cortex. Brain Res. 1994, 646: 181-193.View ArticlePubMedGoogle Scholar
- Cauli B, Audinat E, Lambolez B, Angulo MC, Ropert N, Tsuzuki K, Hestrin S, Rossier J: Molecular and physiological diversity of cortical nonpyramidal cells. J Neurosci. 1997, 17 (10): 3894-3906.PubMedGoogle Scholar
- Cauli B, Tong XK, Rancillac A, Serluca N, Lambolez B, Rossier J, Hamel H: Cortical GABA interneurons in neurovascular coupling: relays for subcortical vasoactive pathways. J Neurosci. 2004, 24 (41): 8940-8949.View ArticlePubMedGoogle Scholar
- Hamel E: Cholinergic modulation of the cortical microvascular bed. Prog Brain Res. Edited by: Descarries L, Krnjevic K, Steriade M. 2004, 145: 171-178.
- Galea E, Fernández-Shaw C, Triguero D, Estrada C: Choline acetyltransferase activity associated with cerebral cortical microvessels does not originate in basal forebrain neurons. J Cereb Blood Flow Metab. 1991, 11 (5): 875-878.View ArticlePubMedGoogle Scholar
- Fukuyama H, Ouchi Y, Matsuzaki S, Ogawa M, Yamauchi H, Nagahama Y, Kimura J, Yonekura Y, Shibasaki H, Tsukada H: Focal cortical blood flow activation is regulated by intrinsic cortical cholinergic neurons. Neuroimage. 1996, 3: 195-201.View ArticlePubMedGoogle Scholar
- Mansvelder HD, Role LW: Neuronal receptors for nicotine: functional diversity and developmental changes. Brain Development: normal processes and the effects of alcohol and nicotine. Edited by: Miller MW. 2006, New York: Oxford University Press, 341-362.View ArticleGoogle Scholar
- Ango F, Di Cristo G, Higashiyama H, Bennett V, Wu P, Huang ZJ: Ankyrin-based subcellular gradient of neurofascin, an immunoglobulin family protein, directs GABAergic innervation at Purkinje axon initial segment. Cell. 2004, 119 (2): 257-272.View ArticlePubMedGoogle Scholar
- Amiry-Moghaddam M, Ottersen OP: The Molecular Basis of Water Transport in the Brain. Nat Rev Neurosci. 2003, 4 (12): 991-1001.View ArticlePubMedGoogle Scholar
- Mechawar N, Descarries L: The cholinergic innervation develops early and rapidly in the rat cerebral cortex: a quantitative immunocytochemical study. Neuroscience. 2001, 108 (4): 555-567.View ArticlePubMedGoogle Scholar
- Buisson B, Bertrand D: Chronic exposure to nicotine upregulates the human α4β2 nicotinic acetylcholine receptor function. J Neurosci. 2001, 21 (6): 1819-1829.PubMedGoogle Scholar
- Ogunshola OO, Stewart WB, Mihalcik V, Solli T, Madri JA, Ment LR: Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res Dev Brain Res. 2000, 119 (1): 139-153.View ArticlePubMedGoogle Scholar
- Rowan RA, Maxwell DS: Patterns of vascular sprouting in the postnatal development of the cerebral cortex of the rat. Am J Anat. 1981, 160 (3): 247-255.View ArticlePubMedGoogle Scholar
- Simionescu M, Ghinea N, Fixman A, Lasser M, Kukes L, Simionescu N, Palade GE: The cerebral microvasculature of the rat: structure and luminal surface properties during early development. J Submicrosc Cytol Pathol. 1988, 20 (2): 243-261.PubMedGoogle Scholar
- Michaloudi H, Batzios C, Grivas I, Chiotelli M, Papadopoulos GC: Developmental changes in the vascular network of the rat visual areas 17, 18 and 18a. Brain Res. 2006, 1103: 1-12.View ArticlePubMedGoogle Scholar
- Masamoto K, Kurachi T, Takizawa N, Kobayashi H, Tanishita K: Successive depth variations in microvascular distribution of rat somatosensory cortex. Brain Res. 2004, 995 (1): 66-75.View ArticlePubMedGoogle Scholar
- Zerlin M, Goldman JE: Interactions between glial progenitors and blood vessels during early postnatal corticogenesis: blood vessel contact represents an early stage of astrocyte differentiation. J Comp Neurol. 1997, 387: 537-546.View ArticlePubMedGoogle Scholar
- Bachy I, Rétaux S: GABAergic specification in the basal forebrain is controlled by the LIM-hd factor Lhx7. Dev Biol. 2006, 291: 218-226.View ArticlePubMedGoogle Scholar
- Wonders CP, Anderson SA: The origin and specification of cortical interneurons. Nat Rev Neurosci. 2006, 7 (9): 687-696.View ArticlePubMedGoogle Scholar
- Fonseca M, dél Río JA, Martínez A, Gómez S, Soriano E: Development of calretinin immunoreactivity in the neocortex of the rat. J Comp Neurol. 1995, 361: 177-192.View ArticlePubMedGoogle Scholar
- Schierle GS, Gander JC, D'Orlando C, Celio MR, Vogt Weisenhorn DM: Calretinin-immunoreactivity during postnatal development of the rat isocortex: a qualitative and quantitative study. Cereb Cortex. 1997, 7 (2): 130-142.View ArticlePubMedGoogle Scholar
- Fogarty M, Grist M, Gelman D, Marín O, Pachnis V, Kessaris N: Spatial genetic patterning of the embryonic neuroepithelium generates GABAergic interneuron diversity in the adult cortex. J Neurosci. 2007, 27 (41): 10935-10946.View ArticlePubMedGoogle Scholar
- Xu Q, de la Cruz E, Anderson SA: Cortical interneuron fate determination: diverse sources for distinct subtypes?. Cereb Cortex. 2003, 13: 670-676.View ArticlePubMedGoogle Scholar
- Dayer AG, Cleaver KM, Abouantoun T, Cameron HA: New GABAergic interneurons in the adult neocortex and striatum are generated from different precursors. J Cell Biol. 2005, 168 (3): 415-427.PubMed CentralView ArticlePubMedGoogle Scholar
- López-Bendito G, Sturgess K, Erdélyi F, Szabó G, Molnár Z, Paulsen O: Preferential origin and layer destination of GAD65-GFP cortical interneurons. Cereb Cortex. 2004, 14 (10): 1122-33.View ArticlePubMedGoogle Scholar
- Soghomonian JJ, Martin DL: Two isoforms of glutamate decarboxylase: why?. Trends Pharmacol Sci. 1998, 19 (12): 500-505.View ArticlePubMedGoogle Scholar
- Kiser PJ, Cooper NG, Mower GD: Expression of two forms of glutamic acid decarboxylase (GAD67 and GAD65) during postnatal development of rat somatosensory barrel cortex. J Comp Neurol. 1998, 402: 62-74.View ArticlePubMedGoogle Scholar
- Paxinos G, Franklin KBJ: The Mouse Brain in stereotaxic coordinates. 2001, New York: Academic Press, 2Google Scholar
- Esclapez M, Tillakaratne NJ, Kaufman DL, Tobin AJ, Houser CR: Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain support the concept of functional differences between the forms. J Neurosci. 1994, 14 (3 Pt 2): 1834-1855.PubMedGoogle Scholar
- Kawaguchi Y, Kubota Y: GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cereb Cortex. 1997, 7 (6): 476-486.View ArticlePubMedGoogle Scholar